Psychiatric manifestations of lupus erythematosus systemic and Sjögren's syndrome;Troubles psychiatriques du lupus érythémateux disséminé et du syndrome de Gougerot-Sjögren: À propos d'une observation d'un syndrome de Gougerot-Sjögren secondaire associé à un lupus érythémateux disséminé

Encephale

Volumn 27, Issue 6, 2001, Pages 588-599

  Ampelas J F ^a   Wattiaux, M J ^b   Vanamerongen, A P ^c  

^a Service ERIC   (France)

^b BICHAT HOSPITAL   (France)

^c CENTRE HOSPITALIER INTERCOMMUNAL   (France)

Author keywords

Central nervous system disease; Lupus erythematosus; Mental disorders; Systemic Sj gren's Syndrome

Indexed keywords

CARBAMAZEPINE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLOPHOSPHAMIDE; FLUOXETINE; GLUCOCORTICOID; HYDROXYCHLOROQUINE; HYDROXYZINE; LITHIUM CARBONATE; LOXAPINE; PHENOTHIAZINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AFFECTIVE NEUROSIS; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DISEASE COURSE; DRUG CONTRAINDICATION; HALLUCINATION; HUMAN; MALE; MENTAL DISEASE; PATHOGENESIS; REVIEW; SIDE EFFECT; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANXIETY DISORDERS; BRAIN; DEPRESSIVE DISORDER, MAJOR; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035705949     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. The American College of rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes
2. Neuropsychiatric manifestations of human leucocyte interferon therapy in patients with cancer
3. Sjögren's Syndrome: CNS Manifestations
4. CNS manifestations of primary Sjögren's syndrome: An overview
5. Central nervous system disease in Sjögren's syndrome
6. Magnetic resonance imaging of cerebral lesions in patients with the Sjögren's syndrome
7. Evidence of an immunopathogenic basis for central nervous system disease in primary Sjögren's syndrome
8. Sjögren's syndrome. Association of cutaneous vasculitis with CNS disease
9. Serum complement activation in central nervous system disease in Sjögren's syndrome
10. Neurologic complications of primary SS
11. Anti-Ro(SSA) autoantibodies in CNS disease associated with SS: Clinical, neuroimaging and angiographic correlates
12. Traitement des maladies systémiques par bolus de cyclophosphamide
13. Association démence «auto-immune», maladie de Basedow, syndrome de Gougerot-Sjögren
14. Lésions neurologiques centrales et périphériques au cours d'un syndrome de Gougerot-Sjögren primitif
15. Fatigue in primary Sjögren's syndrome
16. Chloroquine induced psychiatric complications
17. Primary Sjögren's syndrome: A subjective description of the disease
18. Cerebrospinal fluid antibodies to neuronal cells: Association with neuropsychiatric manifestations of SLE
19. Controversies in lupus: Nervous system involvement
20. Neuropsychiatric manifestations of systemic lupus erythematosus
21. Prevalence of cognitive impairment in SLEs
22. The treatable dementia of Sjögren's syndrome
23. Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: Relations with EEG and MRI findings and clinical manifestations
24. Démence révélatrice du syndrome de Gougerot-Sjögren primitif
25. Proton magnetic resonance spectroscopy of systemic lupus erythematosus involving the central nervous system
26. Central nervous system disease in primary Sjögren's syndrome
27. Cognitive deficits in SLE
28. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells
29. Neuropsychiatric abnormalities in primary Sjögren's syndrome
30. Personality structure disturbances and psychiatric manifestations in primary Sjögren's syndrome
31. Relation entre maladies dysimmunitaires et traits de personnalité chez la femme
32. Central nervous system disease in patients with SLE
33. Pattern of neuropsychologic dysfunction in inactive SLE
34. Manifestations neurologiques centrales du syndrome de Gougerot-Sjögren
35. The study of the psychiatric symptoms of SLE
36. Single photon emission computed tomography scanning in neuropsychiatric SLE
37. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus
38. Elevated levels of interleukin-6 in cerebral fluid from patients with SLE and central nervous system involvement
39. Screening of acute psychiatric admissions for previously undiagnosed systemic lupus erythematosus
40. Mood effects of alternate-day corticosteroid therapy in patients with systemic lupus erythematosus
41. Regional cerebral blood flow and glucose metabolism in SS
42. Primary Sjögren's syndrome with subcortical dementia
43. The psychosocial impact of sle and rheumatoid arthritis
44. Technetium-99m-HMPAO brain SPECT in SLEr with CNS involvement
45. Neuropsychiatric lupus
46. Interferons as mediators of psychiatric morbidity
47. Neuropsychiatric dysfunction in primary SS
48. Manifestations neuropsychiatriques du syndrome de Gougerot-Sjögren primitif: Intérêt de l'IRM cérébrale
49. Troubles psychiques au cours des collagénoses
50. Les troubles psychiques au cours de l'évolution du lupus érythémateux disséminé
51. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus
52. SLE VII. Frequency and impact of secondary Sjøgren's syndrome
53. Mental health status in systemic lupus erythematosus
54. Traitement du lupus érythémateux disséminé
55. Psychodynamic, time-limited group therapy in rheumatic disease - A controlled study with special reference to alexithymia
56. Anti-Ro(SS-A) antibody positive Sjögren's/SLE overlap syndrome
57. Neuropsychiatric lupus and hormones
58. Interferon-alpha in lupus psychosis
59. Sjögren's syndrome associated with pigmentation and sclerodermia of the Leg
60. Neuropsychiatric disease in Sjögren's syndrome: Anti-ribosomal P and anti-neuronal antibodies
61. Keratoconjunctivitis sicca and Sjögren's syndrome
62. Positron emission tomography in neuropsychiatric SLE
63. Functional disability and end organ damage in patients with Systemic Lupus Erythematosus (SLE) and Sjögren's Syndrome (SS)
64. Psychiatric symtoms before SLE is diagnosed
65. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: Results of a prospective multicentre study
66. The time course of acute psychiatric episodes in SLE
67. Neuropsychological functions in systemic lupus erythematosus: A comparison with chronic whiplash patients
68. Psychiatric symptoms in systemic lupus erythematosus: An update
69. Lupus and the central nervous system
70. Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests
71. Drug-induced lupus